Blood Management Strategies in Total Knee Arthroplasty
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
A perioperative blood management program is one of a number of important elements for successful patient care in total knee arthroplasty (TKA) and surgeons should be proactive in its application. The aims of blood conservation are to reduce the risk of blood transfusion whilst at the same time maximizing hemoglobin (Hb) in the postoperative period, leading to a positive effect on outcome and cost. An individualized strategy based on patient specific risk factors, anticipated blood loss and comorbidities are useful in achieving this aim. Multiple blood conservation strategies are available in the preoperative, intraoperative and postoperative periods and can be employed in various combinations. Recent literature has highlighted the importance of preoperative Hb optimization, minimizing blood loss and evidence-based transfusion guidelines. Given TKA is an elective procedure, a zero allogenic blood transfusion rate should be the aim and an achievable goal.
Abstract
A perioperative blood management program is one of a number of important elements for successful patient care in total knee arthroplasty (TKA) and surgeons should be proactive in its application. The aims of blood conservation are to reduce the risk of blood transfusion whilst at the same time maximizing hemoglobin (Hb) in the postoperative period, leading to a positive effect on outcome and cost. An individualized strategy based on patient specific risk factors, anticipated blood loss and comorbidities are useful in achieving this aim. Multiple blood conservation strategies are available in the preoperative, intraoperative and postoperative periods and can be employed in various combinations. Recent literature has highlighted the importance of preoperative Hb optimization, minimizing blood loss and evidence-based transfusion guidelines. Given TKA is an elective procedure, a zero allogenic blood transfusion rate should be the aim and an achievable goal.
참고문헌 (59)
- Eubanks JD, "Antifibrinolytics in major orthopaedic surgery", J Am Acad Orthop Surg, 18, pp.132~138 (2010)
- Noticewala MS, "Predicting need for allogeneic transfusion after total knee arthroplasty", J Arthroplasty, 27, pp.961~967 (2012)
- Shortt J, "Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage : the Bloodhound prospective audit of red blood cell use", Transfusion, 49, pp.2296~2303 (2009)
- Goodnough LT, "Risks, options, and informed consent for blood transfusion in elective surgery", Am J Surg, 159, pp.602~609 (1990)
- Newman ET, "Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty", J Bone Joint Surg Am, 96, pp.279~284 (2014)
- Innerhofer P, "Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty", Transfusion, 45, pp.103~110 (2005)
- Bierbaum BE, "An analysis of blood management in patients having a total hip or knee arthroplasty", J Bone Joint Surg Am, 81, pp.2~10 (1999)
- Hebert PC, "Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care(TRICC)Investigators and the Canadian Critical Care Trials Group", Am J Respir Crit Care Med, 155, pp.1618~1623 (1997)
- Bernard AC, "Intraoperative transfusion of 1 U to 2 Upacked red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients", J Am Coll Surg, 208, pp.931~937 (2009)
- Bower WF, "Perioperative blood transfusion increases length of hospital stay and number of postoperative complications in non-cardiac surgical patients", Hong Kong Med J, 16, pp.116~120 (2010)
- Pierson JL, "A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty", J Bone Joint Surg Am, 86, pp.1512~1518 (2004)
- Loftus TJ, "A patient blood management program in prosthetic joint arthroplasty decreases blood use and improves outcomes", J Arthroplasty, 31, pp.11~14 (2016)
- Holt JB, "Minimizing blood transfusion in total hip and knee arthroplasty through a multimodal approach", J Arthroplasty, 31, pp.378~382 (2016)
- Krebs V, "Eliminating transfusion in primary joint arthroplasty-an achievable goal", J Arthroplasty, 29, pp.1511~ (2014)
- Salido JA, "Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery : analysis of predictive factors", J Bone Joint Surg Am, 84, pp.216~220 (2002)
- Bong MR, "Risks associated with blood transfusion after total knee arthroplasty", J Arthroplasty, 19, pp.281~287 (2004)
- Pola E, "Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty", J Bone Joint Surg Am, 86, pp.57~61 (2004)
- Cuenca J, "Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement", Int J Surg, 5, pp.89~94 (2007)
- Munoz M, "On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery", Blood Transfus, 10, pp.8~22 (2012)
- Spahn DR, "Anemia and patient blood management in hip and knee surgery : a systematic review of the literature", Anesthesiology, 113, pp.482~495 (2010)
- "Guidelines for venous thrombotic episode prophylaxis for hip and knee arthroplasty" (2010)[URL]
- Bruce W, "Practical recommendations for patient blood management and the reduction of perioperative transfusion in joint replacement surgery", ANZ J Surg, 83, pp.222~229 (2013)
- Burger W, "Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation : review and meta-analysis", J Intern Med, 257, pp.399~414 (2005)
- Oscarsson A, "To continue or discontinue aspirin in the perioperative period : a randomized, controlled clinical trial", Br J Anaesth, 104, pp.305~312 (2010)
- Devereaux PJ, "Aspirin in patients undergoing noncardiac surgery", N Engl J Med, 370, pp.1494~1503 (2014)
- Cushner FD, "Blood loss and transfusion rates in bilateral total knee arthroplasty", J Knee Surg, 18, pp.102~107 (2005)
- Biesma DH, "Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin", Lancet, 344, pp.367~370 (1994)
- Cohen JA, "Preoperative autologous blood donation : benefit or detriment? A mathematical analysis", Transfusion, 35, pp.640~644 (1995)
- Birkmeyer JD, "The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement", Transfusion, 33, pp.544~551 (1993)
- Dan M, "Blood loss in primary total knee arthroplasty: body temperature is not a significant risk factor: a prospective, consecutive, observational cohort study", J Orthop Surg Res, 10, pp.97~ (2015)
- Munoz Gomez M, "Pre and post-operative autotransfusion : a comparative study of hematology, biochemistry and red cell metabolism in pre-donated blood and blood from post-operative surgical drainage", Sangre(Barc), 44, pp.443~450 (1999)
- Noon GP, "Intraoperative autotransfusion", Surgery, 84, pp.719~721 (1978)
- Huet C, "A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery : International Study of Perioperative Transfusion(ISPOT)Investigators", Anesth Analg, 89, pp.861~869 (1999)
- Faught C, "Adverse effects of methods for minimizing perioperative allogeneic transfusion : a critical review of the literature", Transfus Med Rev, 12, pp.206~225 (1998)
- Shenolikar A, "Cell salvage auto transfusion in total knee replacement surgery", Transfus Med, 7, pp.277~280 (1997)
- Thomas D, "Autologous blood transfusion in total knee replacement surgery", Br J Anaesth, 86, pp.669~673 (2001)
- Munoz M, "Benefits of postoperative shed blood reinfusion in patients undergoing unilateral total knee replacement", Arch Orthop Trauma Surg, 125, pp.385~389 (2005)
- Randelli F, "Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study", J Arthroplasty, 29, pp.1516~1520 (2014)
- Molloy DO, "Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement : a prospective, randomised controlled trial", J Bone Joint Surg Br, 89, pp.306~309 (2007)
- Parker MJ, "Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst Rev", (3), pp.CD001825~ (2007), Cochrane Database Syst Rev
- Kumar S, "Are drains required following a routine primary total joint arthroplasty?", Int Orthop, 31, pp.593~596 (2007)
- Zacharopoulos A, "The effectiveness of reinfusion after total knee replacement : a prospective randomised controlled study", Int Orthop, 31, pp.303~308 (2007)
- Hazarika S, "A comparison of post-op haemoglobin levels and allogeneic blood transfusion rates following total knee arthroplasty without drainage or with reinfusion drains", Acta Orthop Belg, 76, pp.74~78 (2010)
- Dalen T, "Inflammatory mediators in autotransfusion drain blood after knee arthroplasty, with and without leucocyte reduction", Vox Sang, 85, pp.31~39 (2003)
- Hansen E, "Reasons against the retransfusion of unwashed wound blood", Transfusion, 44(12 Suppl), pp.45S~53S (2004)
- Dunn CJ, "Tranexamic acid : a review of its use in surgery and other indications", Drugs, 57, pp.1005~1032 (1999)
- Tuttle JR, "Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty", J Arthroplasty, 29, pp.1512~1515 (2014)
- Yang ZG, "Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty : a meta-analysis", J Bone Joint Surg Am, 94, pp.1153~1159 (2012)
- Alshryda S, "Tranexamic acid in total knee replacement : a systematic review and meta-analysis", J Bone Joint Surg Br, 93, pp.1577~1585 (2011)
- Kagoma YK, "Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery : a systematic review of randomized trials", Thromb Res, 123, pp.687~696 (2009)
- Patel JN, "Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty : a prospective randomized study", J Arthroplasty, 29, pp.1528~1531 (2014)
- Wong J, "Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty : a randomized, controlled trial", J Bone Joint Surg Am, 92, pp.2503~2513 (2010)
- Alshryda S, "A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement", Bone Joint J, 96, pp.1005~1015 (2014)
- Seo JG, "The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty", Knee Surg Sports Traumatol Arthrosc, 21, pp.1869~1874 (2013)
- Wind TC, "The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty", J Arthroplasty, 28, pp.1080~1083 (2013)
- Ishida K, "Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty", Int Orthop, 35, pp.1639~1645 (2011)
- Soni A, "Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty", J Arthroplasty, 29, pp.1525~1527 (2014)
- Sarzaeem MM, "Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty", J Arthroplasty, 29, pp.1521~1524 (2014)
- Maniar RN, "Most effective regimen of tranexamic acid in knee arthroplasty : a prospective randomized controlled study in 240patients", Clin Orthop Relat Res, 470, pp.2605~2612 (2012)
